Df Dent & CO Inc Abb Vie Inc. Transaction History

Df Dent & CO Inc

$7.62 Billion
Q3 2024

A detailed history of Df Dent & CO Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Df Dent & CO Inc holds 27,812 shares of ABBV stock, worth $4.92 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

27,812

Previous 27,618 0.7%

Holding current value

$4.92 Million

Previous $4.74 Million 15.94%

% of portfolio

0.07%

Previous 0.07%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $31,784 - $38,670	194 Added 0.7%	27,812 $5.49 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $30,338 - $35,428	196 Added 0.71%	27,618 $4.74 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $44,909 - $51,170	281 Added 1.04%	27,422 $4.99 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $728,179 - $820,101	5,292 Added 24.22%	27,141 $4.21 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $161,794 - $201,342	1,221 Added 5.92%	21,849 $2.94 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $174,544 - $201,013	1,207 Added 6.21%	20,628 $3.29 Million
Q4 2022 Feb 15, 2023	BUY	$138.31 - $165.87 $262,097 - $314,323	1,895 Added 10.81%	19,421 $3.14 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $527,847 - $605,406	3,933 Added 28.93%	17,526 $2.35 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $446,026 - $567,045	3,241 Added 31.31%	13,593 $2.08 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $107,299 - $133,128	813 Added 8.52%	10,352 $1.68 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $66,176 - $83,732	-616 Reduced 6.07%	9,539 $1.29 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $6,102 - $6,798	-58 Reduced 0.57%	10,155 $1.14 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $8,591 - $10,083	-100 Reduced 0.97%	10,213 $895,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $18,342 - $24,545	250 Added 2.48%	10,313 $1.01 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $5,869 - $8,898	91 Added 0.91%	10,063 $767,000
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $62,980 - $75,720	1,000 Added 11.15%	9,972 $755,000
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $75,555 - $96,577	1,150 Added 14.7%	8,972 $652,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $6,228 - $7,680	80 Added 1.03%	7,822 $721,000
Q3 2018 Nov 15, 2018	SELL	$88.91 - $98.84 $88,910 - $98,840	-1,000 Reduced 11.44%	7,742 $732,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $111,240 - $148,960	1,209 Added 16.05%	8,742 $827,000
Q4 2017 Feb 15, 2018	SELL	$89.56 - $98.21 $13,344 - $14,633	-149 Reduced 1.94%	7,533 $729,000
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $536,587 - $685,388	7,682	7,682 $683,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Df Dent & CO Inc with notifications on news.

Account